<DOC>
	<DOCNO>NCT02906774</DOCNO>
	<brief_summary>This proof-of-principle research study design determine whether fecal microbiota transplantation ( FMT ) eliminate highly drug-resistant bacteria intestinal tract renal transplant patient . The primary goal study test whether oral gut decontamination follow FMT enema delivery result decolonization intestinal tract renal transplant patient shortly solid organ transplantation , thereby prevent difficult treat post-transplant infection .</brief_summary>
	<brief_title>Fecal Transplant MDR Pathogen Decolonization</brief_title>
	<detailed_description>Contact study principal investigator study protocol .</detailed_description>
	<criteria>Renal transplant patient inclusion criterion : 18 year older Able provide inform consent Positive one target MDR organism rectal stool culture test FMT stool donor inclusion criterion : Able provide inform consent Able complete donor screen Able adhere FMT stool collection test procedure Renal transplant patient exclusion criterion : Still hospital week 7 follow organ transplantation Pregnant planning become pregnant Breastfeeding Participating another interventional investigational study Neutropenic ( ANC &lt; 0.5 ) Colonized Clostridium difficile Presence colostomy ileostomy Has active intestinal infection Fever &gt; 38.0 WBC count &gt; 15,000 Are take nondietary probiotic supplement Require expect require systemic antimicrobial therapy Pneumocystis prophylaxis cytomegalovirus ( CMV ) therapy study period Has severe underlie disease anticipate survival le 6 month Are unable tolerate FMT enema reason , physician believe reason FMT might pose health risk subject Subjects report history anaphylactoid food allergy exclude allergy note donor require avoid ingestion food least three day prior donation FMT stool donor exclusion criterion : Presence follow stool examination : vancomycinresistant Enterococci ( VRE ) , Salmonella , Shigella , shiga toxinproducing E. coli , Yersinia , Campylobacter , ESBL carbapenemaseproducing Enterobacteriaceae ( CRE ) , pathogenic ovum parasite , C. difficile toxin B ( PCR ) , rotavirus , adenovirus norovirus History type active cancer aside melanoma Risk factor acquisition HIV , syphilis , Hepatitis B , Hepatitis C , prion neurological disease determine donor questionnaire History gastrointestinal comorbidities , e.g. , inflammatory bowel disease , irritable bowel syndrome , chronic constipation diarrhea , colostomy ileostomy Receipt blood transfusion country Canada precede 6 month Antibiotic use systemic immunosuppressive agent 3 month prior stool donation Receipt live vaccine within 3 month prior stool donation Any current previous medical psychosocial condition behavior opinion investigator may pose risk recipient donor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>